birdflustocks.com
Home
Facts
Idea
Stocks
Brokers
September 2023
birdflustocks.com
»
2023 September
September 2023
Moderna: mRNA-1010 Seasonal Influenza Vaccine phase 3 study successfully completed
By
admin
|
13
Sep, 23
|
https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-scale-down-manufacturing-covid-vaccine-2023-09-13/
CureVac/GSK: mRNA seasonal influenza vaccine development advances to phase 2 study
By
admin
|
12
Sep, 23
|
Cidara Therapeutics/Johnson & Johnson: CD388 cooperation will continue, stock +26%
By
admin
|
6
Sep, 23
|
Cidara to receive a $7 million milestone payment and is
